Skip to main content

Advertisement

Table 1 (abstract P116). TNF inhibitor treatment

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Uveitis Group Infliximab N=7 (Remission) Adalimumab N= 6 (Remission)
Idiopathic 4 (3) 5 (3)
JIA-U 3 (1) 1 (1)